Zacharias Kyriakakis

Suggest Changes
Learn More
PURPOSE Both docetaxel and cisplatin have moderate activity in patients with advanced urothelial cancer. We performed a multicenter phase II study in order to assess the efficacy and toxicity of the(More)
  • 1